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Abstract 
Background: Splenectomy is a frequently performed operation for patients with portal 
hypertension and hypersplenism in areas endemic for schistosomiasis.  
Reactive thrombocytosis (RT) has been described following splenectomy. Nevertheless, data are 
lacking on the long term changes of platelet count and other blood cells and indices after 
splenectomy in such patients.  
Objectives: To determine the hematological changes following splenectomy in portal hypertension 
due to schistosomiasis. 
Methods: This is a prospective, observational, case study in which we did a series of full blood 
counts before and after splenectomy on two patients. The periods of study were 12 days and 5 
months, respectively. 
Results: Platelets (RT >500x109) occurred after the 7th post-splenectomy day in both patients. In 
the longer study, RT continued from day 8 to week10. Extreme thrombocytosis (> 1000x 109)
occurred from day 11 to day 21 postoperatively. The count was back to normal by week 17. 
Reactive leukocytosis occurred immediately after ligation of the splenic artery, but returned to 
normal levels during the 2nd postoperative week. 
Erythrocytes, however, showed changes different from both platelets and leukocytes. There was 
‘persistent anaemia’ for about one month postoperatively. 
Conclusion: This study provides data that were lacking on the long term haematological effects of 
splenectomy in Sudanese patients with portal hypertension. Knowing these changes can have 
important implications on the management and follow up of such patients, and provide evidence 
needed for discussing guidelines of treatment. 
RT and leukocytosis occur after splenectomy whereas anaemia persists. RT can reach extreme 
levels and it is wise to monitor the platelets after the discharge of patients from the hospital. It may 
also be wise to consider the use of antiplatelet drugs postoperatively till the count normalizes. The 
persistent anaemia, however, seems to correct itself without giving haematinics or blood 
transfusion. 
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plenectomy, alone or as part of a 
devascularization operation, is a 
frequently performed procedure for 
patients with portal hypertension, especially 
in areas endemic for schistosomiasis. 
Common indications include a huge spleen 
and hypersplenism causing anaemia, 
leucopenia, and thrombocytopenia1, 2.
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Normal platelet count is between 100 000- 
450 000/mm3 (100-450x109/L). 
Many authors define thrombocytosis 
(thrombocythaemia) as a count exceeding 500 
000/mm3 (>500x109). Extreme 
thrombocytosis (ET) is a term used when the 
count exceeds 1000 000/mm3 (>1000x 109) 3.
Postsplenectomy reactive thrombocytosis 
(RT) is a wellknown complication that occurs 
in up to 82% of cases. It causes 
thromboembolic complications in about (5%-
10%) of cases according to different authors 
where splenectomy was done mainly for 
trauma and/or malignancy4-6. These 
S
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thromboembolic complications may affect 
veins or arteries. They include portal, 
mesenteric, splenic veins as well as calf 
(deep) vein thrombosis, and the pulmonary 
artery causing pulmonary embolism. Arterial 
thrombosis causing myocardial infarction has 
also been reported 7. Higher incidence of 
portal vein thrombosis, reaching 25% was 
found in patients with idiopathic portal 
hypertension with esophageal varices after 
splenectomy and was related to the decrease 
in portal blood flow8. One of these reports 
found a positive correlation between the 
occurrence of portal thrombosis and the size 
and weight of the removed spleen5.The 
incidence of thrombo-embolism, thus depends 
on the underlying cause of the splenectomy.
Unfortunately data are lacking on patients 
with portal hypertension and hypersplenism 
due to schistosomiasis who undergo 
splenectomy, regarding the extent and 
duration of RT which may reach extreme 
levels.  Moreover, despite the documented 
thrombo-embolic complications mentioned 
above, there are no clear clinical guidelines 
for postoperative prophylaxis against 
thrombocytosis. In fact there are controversial 
reports on the necessity of the use of 
antiplatelet prophylaxis after splenectomy. 
Moreover, data on changes of red blood cells 
(RBCs) and white blood cells (WBCs) after 
splenectomy for portal hypertension and 
hypersplenism are lacking.  
Case Report: 
The first patient was a 50 year old male who 
underwent splenectomy for hypersplenism 
and portal hypertension. He had splenectomy 
and ligation of the left gastric (coronal) vein. 
He was followed up for 12 days. He 
disappeared from follow up after feeling well 
and traveled back to the Western Province of 
Darfur. The peri-operative period was 
uneventful but we noticed that his platelets 
were increasing. They reached (714x109
/L=714000/mm3 or /µL) at day 12 
postoperatively, whereas his RBCs were 
(<5X109 /L) and Hb was still below 10 gm/dl 
(Figures1). 
The patient was lost from follow up. 
However, these data raised our curiosity to 
know about the longer term blood changes 
following splenectomy in patients with portal 
hypertension and hypersplenism and was the 
basis for this study. 
 
Figure1. Patient 1: Showing white blood cells 
(WBC), red blood cells (RBC) and 
haemoglobin (HGB) levels before and after 
splenectomy. Note the ‘persistent anaemia’ 
(HGB<10 gm/dl) up to day 12 post-
splenectomy. 
 
The 2nd patient was, fortunately, from 
Khartoum province and was willing to be 
followed up for a longer period. This was a 35 
year old female who lived in Khartoum 
province all her life. She denies ever living in  
Gazira province which is an endemic area for 
schistosomiasis. She couldn’t remember 
suffering from intestinal schistosomiasis as a 
child. She, however, remembered playing and 
meddling in canals carrying Nile water at 
AlhajYousef (East Blue Nile district of 
Khartoum North). 
The patient was referred to us from the 
medical department as a case of 
hypersplenism secondary to portal 
hypertension due to schistosomalperiportal 
fibrosis diagnosed on ultrasound scan of her 
abdomen. Her portal hypertension was 
diagnosed 12 years before, but she was off 
treatment and had disappeared from follow up 
for about 6 years before presentation. She 
presented with a dragging pain in the left 
upper quadrant area. No history of 
hematemesis, melena, or jaundice. She was 
not diabetic or hypertensive and gave no 
history of blood transfusion. She had a family 
history of diabetes mellitus. She was not a 
cigarette smoker, tobacco snuffer, or alcohol 
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consumer. She was on birth control combined 
pills and a three monthly injection of Depo-
Provera. She had no history of drug allergy. 
On examination, she looked unwell, pale, but 
was not jaundiced. There was no dyspnoea, 
no finger clubbing. Her pulse was 80/min, 
regular with good volume. The blood pressure 
was 110/70. Abdominal examination revealed 
a huge splenomegaly that was 25 cm below 
the left costal margin (Figure2). Examination 
of other systems was normal. 
 
Figure2. Patient2: Note the huge spleen 
extending almost to pubic symphysis. 
 
Her investigations showed anaemia, with 
haemoglobin (HGB) of 7.6 gm/dl, and 
leucopenia with a total white blood cell count 
(TWBC) of 1.8 x 109 /L,and 
thrombocytopenia withplatelet count of 41 x 
109 /L.Urine analysis showed mild infection. 
Both the liver and renal function tests were 
normal. Abdominal ultrasound showed an 
average liver size, displaying extensive 
periportal fibrosis with a dilated portal vein 
measuring 25 mm in diameter. It also showed 
enlarged spleen with dilated splenic vein (22 
mm in diameter). 
Bone marrow aspiration showed hypercellular 
marrow with increased elements 
(megakaryopiosis, erythropoisis, myelopoisis, 
and high erythrocyte/megakaryocyte ratio). 
Iron stain of the bone marrow showed low 
iron deposits. We could not do inflammatory 
factors (e.g. interleukin (IL)-6), erythropoietin 
or thrombopoietin due to lack of facilities. 
The patient received  three units of blood and  
nine units of platelets preoperatively,  four 
units of blood and  seven units of platelets 
and  six units of fresh frozen plasma intra-
operatively. Postoperatively, she was given  
two units of blood and  six units of platelets. 
The splenectomy was done via a long midline 
incision. 
The lesser sac was entered and splenic artery, 
which was abnormally running inferiorly, was 
identified and ligated. A blood sample was 
taken immediately after ligation. The spleen 
was luckily free with no adhesions between it 
and the diaphragm. Splenectomy was 
completed by dividing the gastrosplenic 
vessels. The spleen measured 30 cm x 16 cm 
(Figures 3), and weighed 3 Kilograms. 
Figure3. Spleen measurements (30 cm in 
length. 
 
Blood for complete blood count was drawn 
before, during the operation and 
postoperatively. 
Post operatively the patient was admitted to 
the intermediate care unit for close 
monitoring of her vital signs and general 
clinical condition. We monitored her blood 
count as well as her renal functions daily. 
The patient had an uneventful early recovery. 
She started oral fluid intake at increments of 
30 mls/ hour on the 3rdpos operative day, and 
was allowed free oral intake (diet) by the 5th 
postoperative day. She received broad 
spectrum antibiotics intravenously at 
induction of anaesthesia and continued 
postoperatively. However, on the 3rd 
postoperative day she had two peaks of fever 
at 9:00am   and 12:00 midnight with 
temperature of 39.1oC at its maximum. The 
immune-chromatographic test (ICT) for 
Malaria was positive and Artemether 
injections were given. 
On the 7thpos operative day the patient’s 
respiratory rate increased to 45/min, PR= 100,  
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BP=120/80, Temp= 38.4oC. Her fluid balance 
was negative at (-1.05L/day). There was a 
raised jugular venous pressure (JVP) and a 
chest X-ray revealed a moderate right sided 
pleural effusion. Right sided heart failure and 
pulmonary embolism were suspected. D-
dimer test was 2.3 (normal= less than 
0.3mg/L). Ventilation/perfusion (V/Q scan) 
and CT pulmonary angiography were not 
available. Meanwhile her platelet count 
reached extremely high counts with the peak 
of 1170 x 109/L on the 11thpost operative day. 
The patient was, therefore, started on a 
therapeutic dose of heparin to treat suspected 
pulmonary embolism, as well as small dose of 
Aspirin. Intravenous frusemide to help 
diuresis was given for her right heart failure 
with K supplementation to guard against 
hypokalemia. 
By the 13thpost operative day, the patient’s 
respiratory rate dropped to 24/min and the 
pleural effusion subsided on chest X-ray. 
However, her two daily peaks of high 
temperature didn’t disappear although her 
blood culture was sterile and WBC count was 
normal (7.8x109/L or 7800/mm3). Two 
ultrasound examination of abdomen done by a 
competent radiologist didn’t reveal any intra-
abdominal abscess or portal system 
thrombosis. A careful review of the patient 
with the nursing staff revealed cellulitis at the 
cannula site. The cannula was changed. 
Ciprofloxacin infusion and local mupirocin 
cream were prescribed. Two days later, the 
temperature returned to normal. 
The patient was followed up for an additional 
three days during which she was doing very 
well with no new complaints. The vital signs 
were normal. The surgical wound healed, and 
the platelets started to decrease. The patient 
received pneumococcal and meningococcal 
vaccination as soon as they became available. 
The patient was discharged on the 23rdpost 
operative day in a good condition with a 
platelet count of (865 x 109 /L). As the patient 
was on contraceptive plans before the 
operation, we arranged for the obstetricians to 
see her for advice.  
The patient was scheduled for regular follow 
up visits in the outpatient clinic. The check 
upi ncluded full blood counts which was done 
before each visit for a period of more than 4 
months. 
 
Platelets (Figure 4) 
Preoperatively the platelet count was very low 
(28-32x109/L). Fresh blood and platelet 
transfusion raised the count to 52x109/L on 
theatre day.  
 
Figure4: Posteplenectomy Platelets. 
ReactiveThrombocytosis from day8 to week 
10 with Extreme levels between from day 11 
to day21. 
 
Immediately after ligation of the splenic 
artery at operation, the platelets count started 
to increase. Their number exceeded the 
normal level (RT) after day 7 postoperatively 
(i.e. during the second postoperative week) as 
they did in the first patient (Figure 1). The 
platelet count exceeded the 1000000 mark 
(1000x109/L) at day 11. This extreme 
thrombocytosis (ET) reached a peak 
(1170x109/L) at day 14. It started to go below 
the 1000000 mark from day 21 (965x109/L), 
and continued to decrease gradually and 
slowly. Only at week 17 did it come down to 
the normal range (397x109/L). Hence, RT 
occurred between day 8 and week 17, with 
ET between day 11 and day 19 
postsplenectomy (Table1). 
 
WBCs (Figure 5) 
The pre-operative count was low at 2.3-4.9 
x109/L reaching its lowest level on theatre 
day (2.4x109/L). There was an immediate rise 
(leukocytosis), the WBC count doubled in 
less than half an hour (4.8x 109) after ligation 
of the splenic artery, and increased gradually 
reaching five times the preoperative level 
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(17.4 x109/L) after 24 hours (day 1) 
postoperatively. It reached a peak (20 x109/L) 
after 48 hours. Leukocytosis continued till 
day 10 (12.4 x109/L), then decreased to 
normal level (9.7 x109/L) from day 11, 
staying between 6-7.5 x109/L from week 
seven till the end of the study (week 22). 
 
Table1. Patient2. Blood counts pre- and post-splenectomy. Follow up period 5months. 
 
Time WBC RBC Hb Plt 
PreOp 1.3 1.8 4.21 7.6 41 
PreOp 11.4 1.8 10 40 
PreOp 17.4 2.3 5 11.2 32 
PreOp 22.4 2.5 4.94 11.2 28 
Theatre7.5 2.4 4.14 9.9 52 
23 min after Ligation 4.8 4.95 11.3 64 
1hr 5.3 5 11.9 116 
2.45hr 4.3 4.87 11.4 90 
24 hr(8.5) 17.4 2.8 8.6 150 
48 hr (9.5) 20 2.8 7.3 148 
72hr (10.5) 14.9 2.63 7.3 208 
Day5 (12.5) 12.3 3.6 10.2 145 
Day6 (13.5) 13 4.34 11.3 395 
Day7 (14.5) 14.7 4.03 10.7 409 
Day8 (15.5)W2 12 4.21 11 632 
Day9 (16.5) 11 4.19 10.7 728 
Day10 (17.5) 12.4 4.37 11 902 
Day11 (18.5) 9.7 4.28 10.8 1127 
Day12 (19.5) 6.7 4.84 12.5 1089 
Day13 (20.5) 7.8 4.45 11.4 1092 
Day14 (21.5) 5.5 4.4 11.2 1170 
Day15 (22.5)W3 5.6 3.91 10.2 905 
Day19 (26.5) 5.4 4.3 11.3 1114 
Day21 (28.5) 6.3 4.1 11.7 965 
Day22 (29.5)W4 6.5 4.45 11.6 923 
Day23 (30.5) 9.1 4.3 11.5 865 
Day27 (3.6) 8.6 4.68 12.4 931 
Week5 (10.6) 8.4 4.79 13.1 820 
Week7 (24.6) 6 4.8 12.4 591 
Week8 (1.7) 7.5 4.9 13.2 457 
Week10 (15.7)3rdM 6.6 5.14 13.3 598 
Week17 (27.8) 7.3 5.05 14.4 397 
Week19 (11.9) 6 5 13.2 374 
Week22 (2.10) 6.2 4.8 12.5 391 
During this time the patient had malaria on 
the3rd postoperative day, suspected, but not 
proven- pulmonary embolism between day 
seven and day 13, and fever due to cannula 
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site infection till day 15 postoperatively. The 
WBC remained within normal from day 11 
onwards. The patient did not report any 
complication thereafter and during the follow 
up period of 17 weeks. 
 
Figure5. Post splenectomy White and Red 
blood cells and haemoglobin. Note the 
leukocytosis and persistent anaemia. 
The platelet to WBC ratio was less than 20 
pre-operatively and stayed generally below 20 
till day five (except for one reading after 2.5 
hrs after ligation of splenic artery). Apart 
from malaria that was diagnosed on the 3rd 
postoperative day, there was no evidence of 
infection during this time period. The 
Platelet/WBC ratio increased to above 20 
from day six onwards despite the presence of 
a right-sided pleural effusion that was evident 
on a chest x-ray at day seven. 
 
RBCs 
When we first received the female patient, her 
RBCs and HGB were very low with the latter 
at (7.6 gm/dl).  The patient received blood 
transfusion in the peri-operative period, and 
on theatre day the HGB was 9.9 gm/dl. She 
received four units of blood and seven units 
of platelets and six units of fresh frozen 
plasma intra-operatively. Postoperatively, 
there was no erythrocytosis. In fact there was 
persistent anaemia. She had blood transfusion 
only once, at day three postoperatively which 
elevated the HGB from 7.3 to 10.2 gm/dl. 
Nevertheless, the HGB stayed generally 
below the 11gm/dl mark till day 
11postoperatively, and only reached the 
normal level of 12.4 gm/dl on 27th 
postoperative day. From that day onwards, it 
stayed within the normal range, between 12-
14.4 gm/dl. The patient was not given iron 
tablets at any point. 
 
Other Red Blood Cell indices (Figure 6) 
These included: the haematocrit (HCT) 
(N.36-46%), mean corpuscular volume 
(MCV) (N.83-101 fl), mean corpuscular 
haemoglobin (MCH)(N.27-32pg), and mean 
corpuscular haemoglobin concentration 
(MCHC) (N. 31.5-34.5 gm/dl). All these 
indices confirmed that the preoperative 
anaemia of ‘hypersplenism’, which was 
microcytic hypochromic type, continued for 
about a month postoperatively. They reached 
normal levels together with the RBC count 
and HGB at day 27 postsplenectomy. There 
was no erythrocytosis at any time, in contrast 
to the thrombocytosis and leukocytosis that 
occurred postoperatively. 
 
Figure9. Haematocrit and other RBC indices 
 
The Bone Marrow (BM) 
The patient had a BM aspiration once 
preoperatively and after two weeks post-
operatively. 
The preoperative BM aspiration showed 
hypercellular bone marrow with increased 
elements (Megakaryopiosis, Erythropoisis, 
Myelopoisis, and high E: M ratio). Iron stain 
of the BM showed low iron deposits. The 
postoperative BM showed the same 
preoperative findings.Unfortunately, we could 
not test for inflammatory factors such as (IL-
6), erythropoietin and thrombopoietin, as 
these tests were unavailable. 
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Discussion: 
This study revisits the effects of splenectomy 
on blood cells. However, it focuses on 
patients with portal hypertension and 
hypersplenism caused by schistosomiasis in a 
developing country. 
Platelets changes 
Our results agree with the findings of other 
authors regarding the occurrence of RT (from 
day8-week 17) 9.
The cause-effect relation between RT and the 
occurrence of thrombo-embolic complication 
has been controversial5,9-11.
Those who advocated cause-effect relation5, 11 
identified three risk factors for 
thromboembolism. These included high 
platelet counts (>650x109), a huge spleen 
(>650 gm), and thrombophilia disorders. Both 
the first and second factors were present in 
our patients, and a large spleen is frequently 
seen in portal hypertension patients. 
Hypercoagulable state and increased blood 
viscosity after splenectomy and associated 
with increased platelets and decreased RBC 
deformability were reported12, 13.
From the above studies, it is clear that the risk 
of thromboembolic complications varies 
greatly according to the condition for which 
splenectomy is performed. We think that the 
occurrence of postsplenectomy 
thrombocytosis that can reach extreme levels 
can only add to those risks of thrombo-
embolism in patients with schistosomal portal 
hypertension. 
Most thromboembolic complications occur 7-
35 days after splenectomy6. This coincides 
with the period of RT in our case (day 8 to 
week 10). Our patient developed what we 
thought clinically as pulmonary embolism 
(PE) on day seven and hence we started 
heparin treatment. The score for high clinical 
suspicion of PE is (3), together with the 
tachycardia (1.5), and the history of 
immobilization (1.5) give a score of 6 on 
Well’s criteria14. In addition the D-dimer was 
more than seven times higher than the normal. 
Unfortunately we were not able to do further 
investigations such as pulmonary angiography 
CT scan, or a ventilation perfusion scan to 
prove PE. The patient luckily responded 
promptly to the anticoagulant treatment 
within six days. The patient received a small 
dose of aspirin thereafter for about two 
months. The omission of warfarin and the use 
of aspirin instead occurred unintentionally. 
Although Poullis suggested that aspirin in 
combination with heparin could have 
beneficial effects15, there is no published 
evidence to support the use of aspirin in acute 
pulmonary embolism 16. This case suggests a 
probable benefit when the cause of embolism 
is thrombocytosis. However, this assumption 
needs further study. 
The finding that RT and the extreme peak of 
rise of platelets occurred after the 7th day 
postoperatively and at day 14, respectively, 
should have important implications for 
planning the management and follow up of 
such patients. This is because thrombocytosis 
occurs after patients with uncomplicated 
splenectomy have been discharged from 
hospital9. We, therefore, add our voice to 
those who recommend that post-splenectomy 
patients should be given anti-platelet 
prophylaxis, and have their platelets 
monitored. The regime we propose is aspirin, 
after the 7th postoperative day until the 
platelet count returns to normal. 
Some of our Sudanese patients may travel 
back to their far away homes where medical 
facilities may not be easily available. It is 
therefore important that both surgeons and 
patients know about the risk of 
thromboembolism after splenectomy. Patients 
should be followed up for two weeks at least 
after discharge, at the outpatient department. 
Those patients who need to travel away 
should be strongly advised to stay within a 
reasonable distance from a health facility until 
given the clear, and this is when their platelets 
return to normal. 
RBCs 
Unlike the change (increase) in the platelets 
and WBC count following splenectomy, there 
was no erythrocytosis (or polcythaemia). On 
the contrary, the anaemia persisted for almost 
a month (27 days) after the splenectomy. Our 
finding of ‘persistent anaemia’ following 
splenectomy has been noticed a long time 
before 17. The patient’s HGB was 7.3 g/dl 
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48hrs and 72hrs after the operation despite 
blood transfusion of four units during and in 
the immediate postoperative period. We gave 
her two more units to get her HGB at or just 
above 10 g/dl. This was achieved on the 5th 
post-op day (10.2g/dl). From that day the 
HGB corrected itself gradually to 12 gm/dl by 
the 27th post-op day without further blood 
transfusions or iron tablets. It has to be 
mentioned that there are no National 
Sudanese Haemoglobin Reference values. It 
has been noticed that many Sudanese seem to 
lead normal life with lower HGB levels than 
the international reference range of 12-
15gm/dl female, and 13-17 gm/dl male. The 
cause of this (quasi-anaemia) may be multi-
factorial. Malnutrition and chronic diseases 
such as schistosomiasis and malaria are but a 
few causes. 
Other RBC indices such as HCT, MCH, 
MCHC, MCV showed a microcytic 
hypochromic picture in association with a low 
bone marrow iron. This confirms that the 
cause of the anaemia was hypersplenism. All 
of these returned to normal level after about a 
month postoperatively. The reason why 
erythrocytosis did not occur despite a 
hypercellular bone marrow is not known. 
Relation between reactive thrombocytosis 
and iron deficiency anaemia: 
Iron deficiency anaemia by itself is thought to 
be an important cause of reactive 
thrombocytosis 18. Some authors, such as 
Hirch and Dacy, noted an apparent 
association of persistent anaemia and the late 
occurrence of thrombosis (moths to years), 
and suggested that the persistent anaemia is 
the cause of thrombocytosis17. Our case 
showed, however, the co-existence of 
thrombocytopenia (not thrombocytosis) with 
iron deficiency anaemia for a long time 
before the splenectomy. This, together with 
the leukopenia, was attributed to 
hypersplenism. After splenectomy 
thrombocytosis appeared and reached extreme 
levels while the anaemia persisted and was 
only corrected partially by blood transfusion. 
The anaemia was fully corrected naturally 
after a month while the thrombocytosis 
persisted for about four months 
postoperatively. This pattern does not support 
a causal relationship between iron deficiency 
anaemia and thrombocytosis. In addition, the 
finding of bone marrow 
hypercellularityexplains the thrombocytosis 
as due to increased production of platelets. 
Alteration of the bone marrow megakaryocyte 
count in iron deficiency anaemia was 
mentioned in only two earlier reports 19, 20.
The absence of a causal relationship may 
explain the controversy in literature on the 
mechanism causing RT in iron deficiency 
anaemia, particularly regarding the role of 
erythropoietin, thrombopoietin, cytokines 
such as interleukin 6 and 11, and leukaemia 
inhibitory factor 21, 22. Unfortunately these 
tests were not available to us. 
Cases of central retinal vein thrombosis, and 
carotid artery thrombosis were reported in 
patients with extreme thrombocytosis (not 
after splenectomy) and iron deficiency 
anaemia23, 24. This further supports our 
proposal of using antiplatelet drugs during the 
period of thrombocytosis. We tend, 
nevertheless, to think and agree with Schilling 
et al that the persistent anaemia in the early 
postoperative period may be protective 
against the development of thrombosis25.
This anaemia is fortunate since there is 
usually an increased coagulability of blood 
and increased rigidity of red blood cells 
following splenectomy5, 12, 13. The liability to 
thrombosis would have duplicated if there 
was erythrocytosis. The mechanism that 
orchestrates this anaemia to coincide with the 
period of extreme thrombocytosis (that ended 
at day 21) is, however, unknown. 
The absence of a reactive increase in the 
RBCs (erythrocytosis/polycythaemia) after 
splenectomy is worth thinking about. It could 
suggest that the spleen itself might not be the 
major cause of the anaemia of 
‘hypersplenism’. Other factors may play a 
role, such as chronic infection. It could also 
suggest that the cytological destruction of 
RBCs by the spleen might not be the only 
way the spleen regulates RBC count. The 
spleen might also have an influence on 
erythropoiesis via a humoral factor. Further 
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studies are needed to define the role of spleen 
in the anaemia of portal hypertension. 
WBCs 
Leukocytosis occurred almost immediately 
from 1.3x109 /l to 4.8 x 109 after the ligation 
of the splenic artery at splenectomy. The 
count reached 17x109/l after 24 hours 
postoperatively. There was no evidence of 
infection to which this rise could be attributed 
to. It can only be explained by the 
splenectomy itself.  
The patient postoperative course was 
complicated by malaria infection diagnosed 
by the ICT test on the 3rd postoperative day. 
The WBC count was 14x 109/l. The response 
to the antimalarial treatment was good   and 
by day five the count was 12.5. There was 
another peak on day seven when the WBC 
increased to 14.7 x 109/l. This is the time 
when pulmonary embolism was suspected but 
could not be proven. There was right-sided 
pleural effusion and raised JVP. 
Relationship between platelets and WBCs 
Some reports indicated that, after 
splenectomy for trauma, a platelet (PC)/ 
WBC ratio below 20 on day five 
postoperatively, was a reliable marker of 
infection26, 27. This was because a rise of 
WBC over 15x109/l could markedly decrease 
the ratio. 
Our findings, however, contradict this 
observation. The PC/WBC ratio stayed 
generally below 20 during the preoperative 
period and up to day five postoperatively, 
except at one and 2.5 hours after ligation of 
the splenic artery. Apart from malaria at day 
three postoperatively there was no evidence 
of infection during this period. The platelets 
increased so tremendously thereafter that the 
ratio was well above 20 from day six onwards 
despite the development of pleural effusion. 
 The plt/wbc ratio has, thus, not been a 
reliable evidence of the presence or absence 
of infection after splenectomy for portal 
hypertension. Clinicians have to rely on 
clinical symptoms and signs. 
Conclusion: 
This study provides data for the first time in 
Sudan on the long term haematological 
effects of splenectomy on patients with portal 
hypertension. It has important clinical 
relevance as it provides evidence needed for 
discussing guidelines for management and 
follow up of these patients. 
Blood elements undergo different changes 
post-splenectomy. While the platelet and 
white cells increase, the RBCs (and 
haemoglobin) stay below the normal level. 
The pattern and time of blood cell changes 
also differ. The spleen (and its absence) 
seems to affect blood cell lines differently. 
Reactive thrombocytosis (RT) occurs 
following splenectomy in patients with portal 
hypertension. This phenomenon was noted 
from day seven till week 17, with extreme 
levels (>1000 x109/l) between days 11and 19 
postoperatively. It seems wise to monitor the 
platelet count after discharge of the patient 
from the hospital as this is the time when 
extreme thrombocytosis can occur. It may 
also be wise to give aspirin as a prophylaxis 
against the thrombocytosis from the 5th or 6th 
day postoperatively after the patient starts to 
take oral diet normally until the platelet count 
returns to normal. . 
On the other hand, there seems to be no need 
for blood transfusions or oral iron therapy 
after day seven post-splenectomy, as the 
anaemia will not respond and it will slowly 
correct itself before the end of the first month.  
The persistent anaemia after splenectomy in 
contrast to the RT may suggest that the spleen 
has a different effect on cell lines. Further 
studies are needed to re-investigate the role of 
the spleen in erythropoiesis. 
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